Cargando…
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
BACKGROUND: In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options. METHODS: Using an AI-guided approach, we analyzed > 1000 human lung trans...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297827/ https://www.ncbi.nlm.nih.gov/pubmed/35870428 http://dx.doi.org/10.1016/j.ebiom.2022.104185 |